Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old

The Lancet Infectious Diseases - Tập 6 - Trang 405-410 - 2006
Tom Jefferson1, Eliana Ferroni2, Filippo Curtale3, Paolo Giorgi Rossi3, Piero Borgia3
1Cochrane Vaccines Field, Anguillara Sabazia, Rome, Italy
2Istituto di Igiene, Università Cattolica del Sacro Cuore, Rome
3Servizio Prevenzione e Formazione, Agenzia di Sanità Pubblica della Regione Lazio, Rome

Tài liệu tham khảo

Hausdorff, 2002, Invasive pneumococcal disease in children: geographic and temporal variation in incidence and serotype distribution, Eur J Pediatr, 161, S135, 10.1007/s00431-002-1066-x Whitney, 2003, Decline in invasive pneumococcal disease after the introduction of protein-polysaccaride conjugate vaccine, N Engl J Med, 348, 1737, 10.1056/NEJMoa022823 2000, Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 49, 1 Bogaert, 2005, Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media, J Clin Microbiol, 43, 74, 10.1128/JCM.43.1.74-83.2005 Kaltoft, 2000, Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19-year nationwide surveillance study, Acta Paediatr Suppl, 89, 3, 10.1111/j.1651-2227.2000.tb00775.x Eskola, 1992, Epidemiology of invasive pneumococcal infections in children in Finland, JAMA, 268, 3323, 10.1001/jama.1992.03490230053027 Pedersen, 2004, Systemic pneumococcal disease in Norway 1995–2001: capsular serotypes and antimicrobial resistance, Epidemiol Infect, 132, 167, 10.1017/S0950268803001511 Dahl, 2001, Invasive pneumococcal infections in south western Sweden: a second follow-up period of 15 years, Scand J Infect Dis, 33, 667, 10.1080/00365540110026818 Pineda Solas, 2002, Neumonía neumocócica bacteriémica, An Esp Pediatr, 57, 408, 10.1016/S1695-4033(02)77957-5 Díez-Domingo, 2002, Epidemiology of invasive Streptococcus pneumoniae infections in children in Spain, 1996–1998, J Infect, 45, 139, 10.1016/S0163-4453(02)91051-0 Dominguez, 2002, The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital based study, Vaccine, 20, 2989, 10.1016/S0264-410X(02)00222-0 Iglesias Sánchez, 2002, Epidemiología de la enfermedad invasive neumocócica en Guipuzcoa (1981–2001), An Esp Pediatr, 57, 401, 10.1016/S1695-4033(02)77956-3 Bernaola Iturbe, 2002, Estudio de la incidencia de enfermedad neumocócica invasora entre 0–5 años en el País Vasco y Navarra, An Esp Pediatr, 57, 301, 10.1016/S1695-4033(02)77931-9 Espin, 2002, Enfermedad neumocócica invasiva en niños de la Región de Murcia, Gac Sanit, 16, 385, 10.1016/S0213-9111(02)71947-X Venetz, 1998, Paediatric invasive pneumococcal disease in Switzerland 1985–94, Int J Epidemiol, 27, 1101, 10.1093/ije/27.6.1101 Kyaw, 2000, Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies, Epidemiol Infect, 125, 561, 10.1017/S0950268800004787 Kyaw, 2003, Invasive pneumococcal disease in Scotland, 1999–2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy, Clin Infect Dis, 37, 1283, 10.1086/379016 Rendi-Wagner, 2004, Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria, J Antimicrob Chemother, 53, 826, 10.1093/jac/dkh211 von Kries, 2000, Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines, Clin Infect Dis, 31, 482, 10.1086/313984 Ispahani, 2004, Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation, Arch Dis Child, 89, 757, 10.1136/adc.2003.036921 D'Ancona, 2005, Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy, Vaccine, 23, 2492 Miller, 2000, Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996–1998, Acta Paediatr, 435, S11, 10.1111/j.1651-2227.2000.tb00776.x Smith, 1998, Invasive pneumococcal infection in south and west England, Epidemiol Infect, 120, 117, 10.1017/S0950268897008522 Casado Flores, 2002, Meningitis neumocócica en niños españoles: incidencia, serotipos y resistencia antibiótica. Estudio prospectivo multicéntrico, An Esp Pediatr, 57, 295, 10.1016/S1695-4033(02)77930-7 Curtale, 2005 Decousser, 2004, Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002, Antimicrob Agents Chemother, 48, 3636, 10.1128/AAC.48.9.3636-3639.2004 Ekdahl, 1998, Bacteraemic pneumococcal infections in southern Sweden 1981–1996: trends in incidence, mortality, age-distribution, serogroups and penicillin resistance, Scand J Infect Dis, 30, 257, 10.1080/00365549850160891 Eriksson, 2000, Epidemiology of pneumococcal infections in Swedish children, Acta Paeditr, 435, S35, 10.1111/j.1651-2227.2000.tb00781.x Esposito, 2002, Epidemiologia delle meningiti, delle polmoniti e delle otiti medie pneumococciche in Italia nei soggetti di età pediatrica, Ann Ig, 14, 7 Flamaing, 2002, Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use, J Antimicrob Chemother, 50, 43, 10.1093/jac/dkf086 Gaudelus, 2000, Epidemiology of pneumococcal infections in French children, Acta Paediatr, 435, S27, 10.1111/j.1651-2227.2000.tb00779.x Georges, 2004, Infections invasives à H. influenzae, L. monocytogenes, N. meningitidis, S. pneumoniae, S. agalactiae et S. pyogenes en France en 2001–2002, Bull Epid Hebdo, 34, 165 Hedlund, 2003, Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden, Scand J Infect Dis, 35, 452, 10.1080/00365540310013315 Konradsen, 2002, Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance, Clin Diagn Lab Immunol, 9, 358 Latorre, 2004, Characterisation of invasive pneumococcal isolates in Catalan children up to 5 years of age, 1989–2000, Clin Microbiol Infect, 10, 177, 10.1111/j.1469-0691.2004.00581.x Muhlemann, 2003, Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infections, Switzerland, 1998–1999, J Infect Dis, 187, 589, 10.1086/367994 Nielsen, 1996, Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark 1989–94, Epidemiol Infect, 117, 411, 10.1017/S0950268800059057 Pineda, 2002, Epidemiology of invasive Streptococcus pneumoniae infections in children in an area of Barcelona, Spain, Acta Paediatr, 91, 1251, 10.1111/j.1651-2227.2002.tb00137.x Prymula, 2004, Comparison of Streptococcus pneumoniae serotypes causing acute otitis media & invasive disease in young children in the Czech Republic, Indian J Med Res, 119, 168 Reinert, 1997, Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996, Pediatr Infect Dis J, 16, 244, 10.1097/00006454-199702000-00014 Serrano, 2004, The Portuguese Surveillance Group for the Study of Respiratory Pathogens. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy, Clin Microbiol Infect, 10, 652, 10.1111/j.1469-0691.2004.00869.x Sleeman, 2001, Invasive pneumococcal disease in England and Wales: vaccination implications, J Infect Dis, 183, 239, 10.1086/317924 Syriopoulou, 2000, Epidemiology of invasive childhood pneumococcal infections in Greece, Acta Paediatr, 435, S30, 10.1111/j.1651-2227.2000.tb00780.x Urwin, 1996, Pneumococcal meningitis in the north east Thames region UK: epidemiology and molecular analysis of isolates, Epidemiol Infect, 117, 95, 10.1017/S0950268800001175 Zissis, 2004, Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children, Eur J Paediatr, 163, 364, 10.1007/s00431-004-1447-4 Yu, 1999, Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants, J Infect Dis, 180, 1569, 10.1086/315096 Robbins, 1983, Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups, J Infect Dis, 148, 1136, 10.1093/infdis/148.6.1136 Bergan, 2001, Antibiotic usage in Nordic countries, Int J Antimicrob Agents, 18, 279, 10.1016/S0924-8579(01)00382-X 2002 Trotter, 2005, Ascertainment of meningococcal disease in Europe, Euro Surveill, 10, 247, 10.2807/esm.10.12.00586-en Faustini, 2000, Estimating incidence of bacterial meningitis with capture-recapture method, Lazio region, Italy, Eur J Epidemiol, 16, 843, 10.1023/A:1007650317852 Sniadak, 1995, Potential intervention for the prevention of childhood pneumoniae: geographic and temporal differences in serotype and serogroup distribution of sterile sites pneumococcal isolates from children – implication for vaccine strategies, Pediatr Infect Dis J, 14, 503, 10.1097/00006454-199506000-00007 Hausdorff, 2000, Which pneumococcal serogroup cause the most invasive disease: implication for conjugate vaccine formulation and use, part I, Clin Infect Dis, 30, 100, 10.1086/313608 Vakevainen, 2001, Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants, J Infect Dis, 184, 789, 10.1086/322984 Cartwright, 2002, Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management, Eur J Pediatr, 161, 188, 10.1007/s00431-001-0907-3 Byington, 2005, Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of non vaccine serogroups, Clin Infect Dis, 41, 21, 10.1086/430604 2005, Direct and in direct effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998–2003, MMWR Morb Mortal Wkly Rep, 54, 893 Schutze, 2004, Impact of the conjugate pneumococcal vaccine in Arkansas, Pediatr Infect Dis J, 23, 1125, 10.1097/01.inf.0000145478.36236.1e Obaro, 1996, Carriage of pneumococci after pneumococcal vaccination, Lancet, 348, 271, 10.1016/S0140-6736(05)65585-7 Dagan, 2002, Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers, J Infect Dis, 185, 927, 10.1086/339525 Eskola, 2001, Efficacy of a pneumococcal conjugate vaccine against acute otitis media, N Engl J Med, 344, 403, 10.1056/NEJM200102083440602 Schuchat, 1997, Bacterial meningitis in the United States in 1995, N Engl J Med, 337, 970, 10.1056/NEJM199710023371404